|
|
DaVita Offers Kidney-Friendly Recipes to Beat the Heat - Bradenton Herald |
Bradenton Herald
DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease (CKD), is highlighting kidney-friendly recipes to beat the summer heat blistering much of the country
|
|
|
Gout prevalence swells over the last 2 decades and now stands at 4%. |
|
Science Blog: A new study shows the prevalence of gout in the U.S. has risen over the last twenty years and now affects 8.3 million (4%) Americans.
|
|
Baxter establishes Baxter Ventures to invest in developing therapies. |
|
Marketwatch: Baxter International Inc. BAX +0.14% announced today that it has established Baxter Ventures to invest up to $200 million in equity in promising early-stage companies developing therapies that complement Baxter's existing portfolio.
|
|
Treatment Boosts Survival Rates For Some Kidney Transplant Patients - WBUR |
WBUR
By comparison, only 31 percent of a group of patients who stayed on dialysis were still alive, and 49 percent of another group who had transplants with conventional anti-rejection drugs or remained on dialysis. "It's really a very dramatic difference,"
|
|
FDA accepts NDA to review Affymax, Takeda chronic kidney disease drug - Pharmaceutical Business Review |
Pharmaceutical Business Review
The NDA submission is based on data from two Phase 3 studies (Emerald 1 and 2) which evaluated the efficacy and safety of peginesatide. The study compared once-monthly peginesatide with epoetin in maintaining Hb levels in CKD patients on dialysis with
|
|
|
|
|
<< Start < Prev 771 772 773 774 775 776 777 778 779 780 Next > End >>
|
|
Page 778 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
